AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,407,839 | +170.5% | 64,209 | +102.9% | 0.01% | +150.0% |
| Q3 2022 | $890,000 | -10.0% | 31,638 | +11.2% | 0.00% | 0.0% |
| Q2 2022 | $989,000 | +58.2% | 28,441 | +63.3% | 0.00% | +100.0% |
| Q1 2022 | $625,000 | -79.0% | 17,417 | -86.8% | 0.00% | -95.2% |
| Q2 2020 | $2,970,000 | -33.7% | 132,228 | -56.2% | 0.02% | -53.3% |
| Q1 2020 | $4,481,000 | -21.0% | 301,910 | +2.7% | 0.04% | +15.4% |
| Q4 2019 | $5,673,000 | -30.8% | 294,064 | -28.8% | 0.04% | -39.1% |
| Q3 2019 | $8,196,000 | – | 413,293 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |